Holly Dean

Holly Dean is an accomplished sales professional with extensive experience in the medical device and pharmaceutical industries. Currently serving as Chief Sales Officer (CSO) for Neuromod Devices since July 2021, Holly Dean oversees the company's commercial and government launch of a bi-modal neuromodulation device in the US market, while developing and implementing effective sales strategies. Previously, as Director of US Commercial Sales at Neuromod Devices, responsibilities included seeking FDA approval for innovative medical technology. Holly Dean also held key roles at WSAudiology, where leadership of National Account Managers focused on growing market presence and fostering relationships, and at Phonak, where an emphasis on revenue growth was paramount. Earlier career achievements include significant sales success at Sunovion Pharmaceuticals, contributing to a top-tier product launch. Holly Dean earned a Bachelor of Science in Biology from Louisiana State University Health Sciences Center.